The AMAZES Study: Asthma and Macrolides: the Azithromycin Efficacy and Safety Study (Glebe, Sydney)

Research Centre:
Woolcock Institute of Medical Research
Location:
431 Glebe Point Rd, Glebe, Sydney, NSW (click for map)
Lead Doctor:
Professor Peter Gibson
Ethics Committee:
Approved by the Hunter New England Health Research Ethics Committee

Background

The AMAZES Study research team is aiming to determine whether taking an antibiotic (Azithromycin) alongside normal asthma medications helps to reduce the number of asthma ‘attacks’ and general daily symptoms experienced by adults with asthma. Those patients for whom this study is suitable, will be randomly allocated to take either Azithromycin or placebo tablets over a 48-week period (neither participants nor investigators will know which medication is being taken until the end of the study). Participants will have their asthma closely monitored over the 48-week period and monitoring will continue for an additional 48 weeks after the treatment has ended. Participants will not need to stop taking their regular asthma medication.

Who Can Participate?

  • Adults with asthma (aged 18 and over)
  • who are non-smokers (or ex smokers) and
  • who experience symptoms despite taking regular preventer medication

What Next?

I fit the above eligibility criteria...

  • 1.

    Complete a brief questionnaire by clicking the link below to enter your contact details and answer some eligibility questions.

  • 2.

    The research centre will contact you by phone to discuss the trial and answer your questions.

Next Step: click here to enter your contact details and be contacted by phone about the trial

image

I don't fit the above eligibility criteria...

  • 1.

    Subscribe to our new trial mailing list and be contacted by email about other relevant trials in your area.

Next Step: click here to be contacted about other relevant trials

image